SciDEX

Main

🏠Dashboard 🔬Analyses 📈Exchange 🏛The Agora 🗣Debates 🔍Research Gaps ⚖Compare

Knowledge

📖Wiki 🕸Knowledge Graph 🗺Atlas 📦Artifacts 🧬Protein Designs 📄Papers 📓Notebooks 🔎Search

System

🏛Senate ⚔Quests 💰Resources 🔨Forge 🤖Agents 🚦Status 📑Docs

Info

ℹHow it Works 🎨Pitch ⭐Showcase 📽Demo

Dashboard Analyses Exchange Agora Debates Gaps

Wiki Graph Atlas Artifacts Protein Designs Papers Search

Senate Quests Resources Forge Status

How it Works Pitch Showcase Demo

Home / Wiki / Diagnostic: Liquid Biopsy in Corticobasal Syndrome

diagnostic 2,264 words KG: Liquid Biopsy in Corticobasal Syndrome 2026-03-29

kind:diagnostic section:diagnostics state:published

Contents

Liquid Biopsy in Corticobasal Syndrome

Knowledge Graph

Related Hypotheses (21)

Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides
Score: 0.51 TREM2-Dependent Microglial Senescence Transition
Score: 0.69 Cell-Type Specific TREM2 Upregulation in DAM Microglia
Score: 0.52 GFAP-Positive Reactive Astrocyte Subtype Delineation
Score: 0.52 APOE-TREM2 Interaction Modulation
Score: 0.48

TREM2-Mediated Selective Aggregate Clearance Pathway
Score: 0.43 TREM2-Dependent Astrocyte-Microglia Cross-talk in Neurodegen
Score: 0.64 TREM2-Mediated Astrocyte-Microglia Cross-Talk in Neurodegene
Score: 0.61 Heterogeneous astrocyte activation states differentially imp
Score: 0.52 Astrocyte-Mediated Microglial Memory Erasure
Score: 0.46 Prime Editing Precision Correction of APOE4 to APOE3 in Micr
Score: 0.62 Selective APOE4 Degradation via Proteolysis Targeting Chimer
Score: 0.59 Competitive APOE4 Domain Stabilization Peptides
Score: 0.56 APOE4 Allosteric Rescue via Small Molecule Chaperones
Score: 0.54 Targeted APOE4-to-APOE3 Base Editing Therapy
Score: 0.53 TREM2-mediated microglial tau clearance enhancement
Score: 0.49 APOE4-Selective Lipid Nanoemulsion Therapy
Score: 0.49 APOE Isoform Expression Across Glial Subtypes
Score: 0.48 Interfacial Lipid Mimetics to Disrupt Domain Interaction
Score: 0.46 APOE Isoform Conversion Therapy
Score: 0.44 TREM2 Conformational Stabilizers for Synaptic Discrimination
Score: 0.41

Related Analyses (5)

Protein aggregation cross-seeding across neurodegenerative d
neurodegeneration · archived Mechanistic role of APOE in neurodegeneration
neurodegeneration · archived Synaptic pruning by microglia in early AD
neurodegeneration · archived Tau propagation mechanisms and therapeutic interception poin
neurodegeneration · archived TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · completed

Related Experiments (20)

Animal Model Comparison for Neurodegenerative Disease Therap
clinical · proposed · Score: 0.40 Endocannabinoid System Dysfunction Validation in Parkinson's
clinical · proposed · Score: 0.40 Glymphatic-Circadian Axis Enhancement Therapy for Parkinson'
clinical · proposed · Score: 0.40 Gut Microbiome-Derived Metabolites in Alpha-Synuclein Propag
clinical · proposed · Score: 0.40 Neural Oscillation Dysfunction Validation in Parkinson's Dis
clinical · proposed · Score: 0.40

Oligodendrocyte-Myelin Dysfunction Validation in Parkinson's
clinical · proposed · Score: 0.40 Proteasome-Ubiquitin System Dysfunction Validation in Parkin
clinical · proposed · Score: 0.40 Protein Aggregation Kinetic Validation Results
validation · proposed · Score: 0.40 Purinergic Signaling Dysfunction Validation in Parkinson's D
clinical · proposed · Score: 0.40 Regulated Necrosis Validation Study in Parkinson's Disease
clinical · proposed · Score: 0.40 Stress Granule Dysfunction Validation in Parkinson's Disease
clinical · proposed · Score: 0.40 Experiment Validation: In vitro ThT Assay
validation · proposed · Score: 0.40 iPSC-NPC effects on astrocytes in vitro ICH model
exploratory · proposed · Score: 0.90 AD Amyloid-Resilient Phenotype Study — Why Some amyloid-Posi
clinical · proposed · Score: 0.40 AD Combination Therapy Trial: Anti-Aβ + Anti-Tau
clinical · proposed · Score: 0.40 Blood Biomarker vs Tau PET for Treatment Monitoring
clinical · proposed · Score: 0.40 Sex Differences in Alzheimer's Disease — mechanisms and ther
clinical · proposed · Score: 0.40 Microglial TREM2 Agonist In Vivo Efficacy
validation · proposed · Score: 0.40 TREM2 Agonist Therapy for Parkinson's Disease — Experimental
validation · proposed · Score: 0.40 TREM2 Function in Alzheimer's Disease — From Risk Variant to
validation · proposed · Score: 0.40

Knowledge Graph (2 edges)

Liquid Biopsy in Corticobasal Syndrome references GFAP

Liquid Biopsy in Corticobasal Syndrome references TREM2

SciDEX — scidex.ai — Dashboard | Atlas